Glucose-6-phosphate dehydrogenase deficiency: a historical perspective

Slides:



Advertisements
Similar presentations
Glucose 6-phosphate dehydrogenase deficiency
Advertisements

Case Study MICR Hematology Spring, 2011
Pentose Phosphate Pathway Generation of NADPH and Pentoses COURSE TITLE: BIOCHEMISTRY 2 COURSE CODE: BCHT 202 PLACEMENT/YEAR/LEVEL: 2nd Year/Level 4, 2nd.
Enzymopathies = ENZYME DEFECTS
Alternative ways of monosaccharides metabolism.. Glucose The fate of glucose molecule in the cell Glucose-6- phosphate Pyruvate Glycogen Ribose, NADPH.
Kunwardeep Sohal, R3  2 ways to destroy RBC: issues within the RBC and/or its membrane (intracorpuscular defects) vs extracorpuscular  Examples of.
1 Biochemistry 3070 Hexose Monophosphate Shunt. 2 Biological systems utilize a variety of simple sugars which must be synthesized by the cell. These sugars.
Lecture # 7 Pentose Phosphate Pathway
Pentose Phosphate Pathway Generation of NADPH and Pentoses.
Fructose Metabolism Fructose can enter glycolysis and gluconeogenesis. Glucose is a main metabolic fuel in most organisms. Other sugars convert to glycolytic.
DR. SAIDUNNISA, MD Professor of Biochemistry Hexose monophosphate shunt.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Dr. Saidunnisa, MD Professor of Biochemistry
MLAB 1415-Hematology Keri Brophy-Martinez
TYPES OF HEMOGLOBINS & HEMOGLOBINOPATHIES
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof
PENTOSE PATHWAY & ANTIOXIDANTS BIOC DR. TISCHLER LECTURE 26.
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY This pathway consists of two parts: 1) Glucose-6-P undergoes two oxidations by NADP +, the second.
TCA & Pentose Phosphate Pathway 12/01/2009. Citrate Synthase.
Glucose -6-phosphate dehydrogenase deficiency
Case Study 1: G6PD David Grkovicious Andrew Wattals Tim Cryal.
Glucose-6-Phosphate Dehydrogenase
Pentose phosphate pathway (hexose monophosphate shunt) READING: Harpers Biochemistry Chapter 22 Lehninger Principles of Biochemistry 3rd Ed. pp
GLUCOSE-6-PHOSPATE DEHYDROGENASE DEFICIENCY GENETICS PRESENTATION BY GROUP A2(MD2) WINDSOR UNIVERSITY SCHOOL OF MEDICINE. IVEREN,FOLA,FLOURISH, ALLISON,
The Citric Acid Cycle and the Pentose Phosphate Pathway.
Glucose-6-Phosphate Dehydrogenase
Glucose 6-phosphate dehydrogenase deficiency HMIM224.
The Pentose Phosphate Pathway. Glucose The fate of glucose molecule in the cell Glucose-6- phosphate Pyruvate Glycogen Ribose, NADPH Pentose phosphate.
Hemolytic anemias.
HEXOSE MONO PHOSPHATE SHUNT
MLAB 1415-Hematology Keri Brophy-Martinez Hemolytic Anemias: Enzyme Deficiencies.
Inherited and acquired haemolytic anaemias
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
Glucose-6-Phosphate Dehydrogenase
Glucose-6-phosphate Dehydration Deficiency
Overviw Red cell enzyme Red cell enzyme Glucose-6-phosphate dehydrogenase deficiency Glucose-6-phosphate dehydrogenase deficiency Causes: Causes: Symptoms.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
Lab 9 G6PD Daheeya AlEnazi.
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY This pathway consists of two parts: 1) Glucose-6-P undergoes two oxidations by NADP +, the second.
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase–deficient children receiving dapsone by Allan Pamba, Naomi D. Richardson,
MANGEMENT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Glucose-6-Phosphate Dehydrogenase Deficiency
Glucose-6-PhosphateDehydrogenase Deficiency Glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most frequent disease involving enzymes of the.
Anemia By: Dr Sunita Mittal.
Pentose Phosphate Pathway
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice by Lara Krieg, Oren Milstein, Philippe Krebs, Yu.
Pentose Phosphate Pathway
PENTOSE PHOSPHATE SHUNT or HEXOSE MONOPHOSPHATE PATHWAY
Hexose Monophosphate Shunt (HMP Shunt)
Metabolism of red blood cells and white blood cells
by Renato D. Lopes, John D. Horowitz, David A. Garcia, Mark A
Glucose-6-Phosphate Dehydrogenase
The hexose monophosphate shunt
Do reactive oxygen species play a role in myeloid leukemias?
OBJECTIVES To understand the function of the pentose phosphate pathway in production of NADPH and ribose precursors for nucleic acid synthesis. To examine.
Red cell adenylate kinase deficiency: molecular study of 3 new mutations (118G>A, 190G>A, and GAC deletion) associated with hereditary nonspherocytic hemolytic.
Red cells from glutathione peroxidase-1–deficient mice have nearly normal defenses against exogenous peroxides by Robert M. Johnson, Gerard Goyette, Yaddanapudi.
by Sean X. Gu, Jeff W. Stevens, and Steven R. Lentz
Pentose phosphate pathway (PPP or HMPP)
Molecules of Life: Macromolecules
Detection of bone marrow–derived lung epithelial cells
A “Reductionist” View of Cardiomyopathy
Osmotic fragility of the RBCs
Advances in the Treatment of Sickle Cell Disease
Approach to Haemolysis
Pentose phosphate pathway (hexose monophosphate shunt)
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency  Shannon.
G6PD Deficiency and Induced Hemolysis
Presentation transcript:

Glucose-6-phosphate dehydrogenase deficiency: a historical perspective by Ernest Beutler Blood Volume 111(1):16-24 January 1, 2008 ©2008 by American Society of Hematology

Chromium 51 studies showing that primaquine sensitivity was due to an intrinsic defect of the red blood cell. Chromium 51 studies showing that primaquine sensitivity was due to an intrinsic defect of the red blood cell. (A) Red cells from a primaquine-sensitive volunteer were labeled with chromium 51 and transfused into normal recipients. Three of these recipients were given 30 mg primaquine daily as shown by the bars. (B) Red cells from a primaquine-nonsensitive volunteer were labeled with chromium 51 and transfused into a normal and one primaquine-sensitive volunteer (D.J.). Two of the subjects were given primaquine, including D.J., who was primaquine sensitive. The fall of the hematocrit of D.J. is shown in the lower panel B. (Reprinted from Dern et al67 with permission from Elsevier.)‏ Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology

The Heinz body test for primaquine sensitivity (G6PD deficiency). The Heinz body test for primaquine sensitivity (G6PD deficiency). The cells (right) are from a primaquine-sensitive (G6PD-deficient) donor; the cells in the left panel, from a normal control. Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology

A plausible series of reactions that could explain the lack of resistance of G6PD-deficient red cells to oxidative stress. A plausible series of reactions that could explain the lack of resistance of G6PD-deficient red cells to oxidative stress. The interaction of drugs with red cells produces hydrogen peroxide, either directly or by way of reactive oxygen species. Glutathione removes the peroxide through the glutathione peroxidase reaction and continues to do so as long as the oxidized glutathione formed is able to be reduced through the glutathione reductase reaction. The latter reaction, requiring continual reduction of NADP to NADPH, is dependent on the G6PD reaction and fails in red cells deficient in this enzyme. (Reprinted from Beutler68 with permission from FASEB.)‏ Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology

The effect of 8 different drugs on the survival of primaquine-sensitive red cells transfused into normal volunteers. The effect of 8 different drugs on the survival of primaquine-sensitive red cells transfused into normal volunteers. Primaquine, sulfanilamide, acetanilid, phenylhydrazine, sulfoxone, and phenacetin in the doses shown cause significant hemolysis of the primiquine-sensitive cells. Hydroxyacetanilid and para-aminobenzoic acid did not prove to be hemolytic. (Reprinted from Dern et al17 with permission from Elsevier.)‏ Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology

The author and Dr Susumo Ohno (left), whose original observations of the morphology of the mammalian X-chromosome provided the author with the idea that only one of the 2 X-chromosomes was active, the other undergoing inactivation in early embryogenesis. The author and Dr Susumo Ohno (left), whose original observations of the morphology of the mammalian X-chromosome provided the author with the idea that only one of the 2 X-chromosomes was active, the other undergoing inactivation in early embryogenesis. This photograph was taken in my laboratory at the City of Hope Medical Center and published in Time Magazine, January 4, 1963, to accompany a feature article entitled, “Research Makes It Official: Women Are Genetic Mosaics.” The insert shows the hyperchromatic X-chromosome of a female. The photographer paid no heed to the author's insistence that the burette with which we are posed had nothing to do with X-inactivation. Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology

An indirect histochemical stain of erythrocytes from a heterozygote for G6PD deficiency who was suffering from naturally acquired malaria. An indirect histochemical stain of erythrocytes from a heterozygote for G6PD deficiency who was suffering from naturally acquired malaria. The more pigmented cells are those that contain normal G6PD activity. They contain the highest percentage of malaria parasites, as shown by the arrows. (Courtesy Professor Lucio Luzzatto.)‏ Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology

The region of the human G6PD molecule in which the subunits form contacts. The region of the human G6PD molecule in which the subunits form contacts. The numbers indicate the amino acids that are altered to produce type I variants, those that cause hereditary nonspherocytic anemia. Two subunits are shown. The NADP bound by one subunit is shown in orange; the other NADP is shown in purple. (Courtesy Drs Margaret Adams, Sheila Gover, and Shannon Au.)‏ Ernest Beutler Blood 2008;111:16-24 ©2008 by American Society of Hematology